Skip to main content
. 2020 Jul 31;42(4):633–640. doi: 10.1038/s41401-020-0465-8

Fig. 6. NG52 potently inhibits glioma in vivo.

Fig. 6

a Comparison of the final tumor weight in each group after the 17-day treatment period with NG52, n = 5. b Mice engrafted with PDXs received vehicle or NG52 for 17 days. Representative photographs of the tumors in each group are shown, n = 5. c Body weight measurements from the mice after 17 days of NG52 administration. The initial body weight was set as 100%, n = 5.